Gjermeni E, Kirstein AS, Kolbig F, Kirchhof M, Bundalian L, Katzmann JL, Laufs U, Blher M, Garten A, Le Duc D (2021) ObesityAn update on the Basic Pathophysiology and Review of recent therapeutic advances
Since CagriSema already contains semaglutide 2.4 mg, transitioning from standalone semaglutide to CagriSema would theoretically be simpler, though clinical guidance on this transition is limited
The link between neuronal dysfunction and depression is well-established (55, 56), and numerous researches have explored the association between cholesterol and neuronal deficits (57)
Reported adverse effects included mild injection site reactions and transient headaches
It is important to note that there was not full recovery from APAP-associated toxicity a month after the treatment
High homocysteine is also linked to low mood, migraines, cognitive decline, dementia and poor memory function